Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Organics Limited was incorporated in 1989 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 138 Cr
P/E 13.40
Div Yield 3.04 %
Book Value βΉ107.00
52w High βΉ154.00
52w Low βΉ86.10
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
24.67
31.07
26.73
25.32
23.56
28.37
26.24
27.18
26.05
31.27
25.61
23.71
24.63
Expenses
21.35
28.64
22.95
21.82
19.81
23.60
21.70
22.05
21.62
26.54
20.70
19.28
19.75
Operating Profit
3.32
2.43
3.78
3.50
3.75
4.77
4.54
5.13
4.43
4.73
4.91
4.43
4.88
OPM %
13.46
7.82
14.14
13.82
15.92
16.81
17.30
18.87
17.01
15.13
19.17
18.68
19.81
Other Income
0.52
1.25
1.06
0.64
0.66
0.00
0.96
0.70
0.74
0.13
1.22
1.01
0.10
Depreciation
0.65
0.59
0.60
0.58
0.56
0.51
0.58
0.56
0.54
0.56
0.39
0.41
0.38
Interest
0.08
0.04
0.09
0.08
0.06
0.09
0.08
0.14
0.06
0.05
0.05
0.11
0.07
Profit before tax
3.11
3.05
4.15
3.48
3.79
4.17
4.84
5.13
4.57
4.25
5.69
4.92
4.53
Tax %
25.72
43.93
11.33
25.00
25.07
23.98
24.17
26.12
24.95
34.59
25.13
25.20
25.17
Net Profit
2.31
1.70
3.68
2.61
2.85
3.17
3.67
3.79
3.43
2.78
4.26
3.69
3.39
EPS in Rs
1.75
1.29
2.79
1.98
2.16
2.41
2.79
2.88
2.60
2.11
3.62
3.13
2.88
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
107.00 107.00 105.00 103.00 69.00 49.00 50.00 48.00 42.00 40.00 40.00 36.00
Expenses
93.00 90.00 86.00 83.00 56.00 41.00 42.00 41.00 35.00 33.00 34.00 31.00
Operating Profit
14.00 18.00 19.00 20.00 13.00 9.00 9.00 7.00 7.00 7.00 6.00 5.00
OPM %
13.00 16.00 18.00 19.00 19.00 18.00 17.00 14.00 16.00 17.00 14.00 13.00
Other Income
4.00 3.00 2.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest
0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 1.00 0.00 1.00 1.00
Depreciation
2.00 2.00 2.00 2.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Profit before tax
14.00 18.00 19.00 19.00 11.00 7.00 7.00 6.00 5.00 5.00 4.00 3.00
Tax %
25.00 24.00 27.00 26.00 27.00 31.00 28.00 29.00 29.00 36.00 27.00 32.00
Net Profit
11.00 14.00 14.00 14.00 8.00 5.00 5.00 4.00 4.00 3.00 3.00 2.00
EPS in Rs
8.22 10.47 10.71 11.94 8.33 5.01 5.29 4.04 3.67 3.21 3.04 1.90
Dividend Payout %
10.00 8.00 7.00 7.00 18.00 20.00 0.00 12.00 14.00 16.00 17.00 13.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
13.00 13.00 13.00 12.00 10.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves
128.00 121.00 112.00 84.00 37.00 35.00 30.00 25.00 22.00 19.00 16.00 13.00
Borrowings
6.00 5.00 6.00 6.00 4.00 4.00 4.00 5.00 6.00 7.00 5.00 7.00
Other Liabilities
25.00 24.00 28.00 21.00 22.00 14.00 12.00 9.00 12.00 9.00 11.00 8.00
Total Liabilities
172.00 163.00 159.00 123.00 74.00 58.00 52.00 44.00 44.00 39.00 37.00 33.00
Fixed Assets
20.00 18.00 14.00 8.00 7.00 7.00 6.00 7.00 7.00 8.00 7.00 7.00
CWIP
17.00 15.00 6.00 4.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 0.00
Investments
0.00 0.00 3.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
135.00 131.00 137.00 111.00 65.00 49.00 44.00 36.00 36.00 30.00 28.00 26.00
Total Assets
172.00 163.00 159.00 123.00 74.00 58.00 52.00 44.00 44.00 39.00 37.00 33.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
10.00 4.00 10.00 0.00 -2.00 5.00 5.00 2.00 3.00 1.00 3.00 1.00
Cash from Investing Activity
-7.00 -16.00 -7.00 -34.00 0.00 -1.00 -2.00 -1.00 -1.00 -2.00 -2.00 -1.00
Cash from Financing Activity
-4.00 -5.00 16.00 36.00 -1.00 -2.00 -1.00 -2.00 -2.00 1.00 -1.00 0.00
Net Cash Flow
-1.00 -18.00 18.00 1.00 -2.00 3.00 1.00 0.00 0.00 0.00 -1.00 0.00
Free Cash Flow
3.00 -12.00 0.00 -4.00 -3.00 3.00 4.00 1.00 2.00 -1.00 0.00 0.00
CFO/OP %
103.00 48.00 82.00 28.00 5.00 85.00 73.00 63.00 79.00 45.00 69.00 46.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
134.00 119.00 137.00 137.00 172.00 140.00 164.00 137.00 170.00 138.00 134.00 142.00
Inventory Days
230.00 246.00 211.00 181.00 237.00 246.00 186.00 164.00 185.00 185.00 155.00 154.00
Days Payable
90.00 88.00 114.00 89.00 158.00 152.00 111.00 73.00 124.00 83.00 109.00 80.00
Cash Conversion Cycle
274.00 276.00 234.00 230.00 251.00 235.00 239.00 229.00 231.00 240.00 181.00 216.00
Working Capital Days
203.00 204.00 178.00 173.00 192.00 167.00 170.00 155.00 150.00 137.00 138.00 136.00
ROCE %
10.00 14.00 17.00 26.00 25.00 19.00 20.00 18.00 18.00 20.00 19.00 14.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
56.12
56.12
56.12
56.12
56.12
56.12
56.12
56.12
56.12
58.08
58.08
58.08
DIIs
0.00
0.00
0.00
0.00
0.00
0.98
1.14
1.14
0.00
0.00
0.00
0.00
Public
43.88
43.89
43.89
43.87
43.87
42.89
42.74
42.74
43.87
41.92
41.93
41.92
No. of Shareholders
7,966
8,099
8,364
8,783
8,344
8,248
8,092
7,854
7,960
8,140
8,073
6,794
Corporate Actions
31 records
Back to all stocks